Co-sponsored Seminar

Morning Seminar

Morning Seminar1July 11, 2025, 08:00-08:50 (Room1 / Convention Hall A)

Chair	Tadakazu Hisamatsu (Department of Gastroenterology and Hepatology, Kyorin University School of Medicine)
Speakers	Expanding Horizons in Inflammatory Bowel Disease with Skyrizi as a First-Line Biologic for CD Kazuhiko Uchiyama (Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine)
Co-sponsored by	AbbVie GK

AbbVie GK

Morning Seminar2July 11, 2025, 08:00-08:50 (Room2 / Convention Hall B)

Chair	Masanao Nakamura (Associate Professor and Director, Department of Endoscopy, Nagoya University hospital)
Speakers	Efficacy and Safety of Three JAK Inhibitors for Ulcerative Colitis: A Large-Scale Real-World Date from Japan Shintaro Akiyama (Department of Gastroenterology, Institute of Medicine, University of Tsukuba, Tsukuba Institute for Advanced Research)
Co-sponsored by	Gilead Sciences K.K. / EA Pharma Co., Ltd.

AbbVie GK

Morning Seminar3July 11, 2025, 08:00-08:50 (Room3 / Meeting Room 201)

The Hidden Burden of IBD Tackling Iron Deficiency Anemia

Chair	Fumihito HIRAI (Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University)
Speakers	Iron and the Gut -Unlocking Solutions for IDA in IBD- Ken TAKEUCHI (Director of the IBD Center, Department of Gastroenterology, IBD Center, Tsujinaka Hospital Kashiwanoha)
Speakers	Beyond the Gut: Comprehensive Care for IBD Patients Masayuki SARUTA (Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine)
Co-sponsored by	ZERIA Pharmaceutical Co.,Ltd

AbbVie GK

Morning Seminar4July 12, 2025, 08:00-08:50 (Room1 / Convention Hall A)

Chair	Kenji Watanabe (Department of Internal Medicine for Inflammatory Bowel Disease, Toyama University)
Speakers	New Solutions for Unmet Needs in UC:The Promise of Ozanimod Taku Kobayashi (Center for Advanced IBD Research and Treatment, Kitasato University, Kitasato Institute Hospital)
Co-sponsored by	Bristol-Myers Squibb

Morning Seminar5July 12, 2025, 08:00-08:50 (Room2 / Convention Hall B)

Chair	Toshifumi Hibi (Professor Emeritus, Keio University)
Speakers	Decoding IBD pathogenesis through host - microbiota interactions. Nobuhiko Kamada (Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan / Professor, Department of Pathology, University of Michigan / Specially Appointed Professor, WPI Immunology Frontier Research Center, University of Osaka)
Co-sponsored by	Miyarisan Pharmaceutical Co., Ltd

Morning Seminar6July 12, 2025, 08:00-08:50 (Room3 / Meeting Room 201)

Chair	Mikihiro Fujiya (Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University)
Speakers	Treatment strategy in refractory ulcerative colitis:How to use Vedolizumab Makoto Naganuma (Division of Gastroenterology and Hepatology, Third Department of Internal Medicine, Kansai Medical University)
Co-sponsored by	Takeda Pharmaceutical Company Limited

Luncheon Seminar

Luncheon Seminar1July 11, 2025, 12:00-12:50 (Room1 / Convention Hall A)

Chair	Katsuyoshi Matsuoka (Toho University, Faculty of Medicine, Sakura Medical Center)
Speakers	Pioneering the Future of Crohn’s Disease treatment -The Possibility of a New Standard of Care- Tadakazu Hisamatsu (Kyorin University School of Medicine, Department of Gastroenterology and Hepatology)
Co-sponsored by	Janssen Pharmaceutical K.K.

Luncheon Seminar2July 11, 2025, 12:00-12:50 (Room2 / Convention Hall B)

Foundations for Success - Tight Monitoring + Comprehensive Action = Mucosal Healing

Chair	Taku Kobayashi (Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital)
Speakers	Clinical Approach to STRIDE-II in Real-Life Settings: Analysis and Practical Recommendations Fernando Magro (Faculty of Medicine, Porto University)
Speakers	Intestinal Ultrasound for Inflammatory Bowel Disease in Daily Practice Jun Miyoshi (Department of Gastroenterology and Hepatology, Kyorin University School of Medicine)
Co-sponsored by	AbbVie.GK Medical Affiars

Luncheon Seminar3July 11, 2025, 12:00-12:50 (Room3 / Meeting Room 201)

Chair	Shinichiro Shinzaki (Department of Gastroenterology, Hyogo Medical University School of Medicine)
Speakers	Management of Small Bowel Lesions in Crohn’s Disease:Biomarkers, Imaging, and Therapeutics Kento Takenaka (Department of Gastroenterology and Hepatology, Institute of Science Tokyo)
Co-sponsored by	Takeda Pharmaceutical Company Limited

Luncheon Seminar4July 12, 2025, 12:00-12:50 (Room1 / Convention Hall A)

Cutting-edges of Ulcerative Colitis Treatment: focusing on Introduction of Oral Advanced Therapy

Chair	Toshifumi Hibi (Special Adviser, IBD Center Kitasato University Kitasato Institute Hospital)
Speakers	Motohiro Esaki (Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University)
Speakers	Geert D'Haens (The department of Gastroenterology and Hepatology, Amsterdam University Medical Centers)
Co-sponsored by	Pizer Japan Inc.

Luncheon Seminar5July 12, 2025, 12:00-12:50 (Room2 / Convention Hall B)

Chair	Ryuichi Okamoto (Department of Gastroenterology and Hepatology Institute of Science Tokyo)
Speakers	Advances in the Management of Ulcerative Colitis: 2025 David Todd Rubin (Section of Gastroenterology, Hepatology and Nutrition, Director, Digestive Diseases Center University of Chicago)
Co-sponsored by	Bristol-Myers Squibb

Luncheon Seminar5

Luncheon Seminar6July 12, 2025, 12:00-12:50 (Room3 / Meeting Room 3)

Chair	Hiroshi Nakase (Division of Gastroenterology and Hepatology, Department of Internal Medicine Sapporo Medical University School of Medicine)
Speakers	Optimization and maximization of advanced therapy for Crohn's disease in the era of multiple options Kenji Watanabe (Department of Internal Medicine for Inflammatory Bowel Disease, Toyama University)
Co-sponsored by	Mochida Pharmaceutical CO., LTD.

Luncheon Seminar6

Evening Seminar

Evening Seminar1July 10, 2025, 17:00-17:50 (Room1 / Convention Hall A)

Chair	Shuhei Hosomi (Department of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University)
Speaker	Treatment of Perianal Crohnʼs disease: Comprehensive Approach and Clinical Practice Takashi Yokoo (Dongo Digestive & Anal Disease Center)
Co-sponsored by	Mitsubishi Tanabe Pharma Corporation

Evening Seminar2July 10, 2025, 17:00-17:50 (Room2 / Convention Hall B)

Chair	Makoto Naganuma (Kansai Medical University, Osaka, Japan)
Speakers	LRG: A New Frontier in the Management of IBD Ami Kawamoto (Institute of Science Tokyo, Tokyo, Japan)
Co-sponsored by	SEKISUI MEDICAL / EA Pharma

Evening Seminar3July 11, 2025, 17:00-17:50 (Room1 / Convention Hall A)

Cutting-edges of Ulcerative Colitis Treatment: focusing on Introduction of Oral Advanced Therapy

Chair	Hiroshi Nakase (Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine)
Speakers	David T. Rubin (Hepatology & Nutrition and the Director of the Inflammatory Bowel Disease Center at The University of Chicago Medicine)
Speakers	Ken Takeuchi (Manager of IBD Centre Tsujinaka Hospital Kashiwanoha)
Co-sponsored by	Pfizaer Japan Inc.

Evening Seminar4July 11, 2025, 17:00-17:50 (Room2 / Convention Hall B)

Chair	Takanori Kanai (Division of Gastroenterology & Hepatology Department of Internal Medicine Keio University School of Medicine)
Speakers	Pioneering the Future of Ulcerative Colitis treatment -The Possibility of a New Standard of Care- Remo Panaccione (University of Calgary Cumming School of Medicine, Department of Medicine \| Gastroenterology)
Co-sponsored by	Janssen Pharmaceutical K.K.

Sponsered Session

Sponserd SessionJuly 11, 2025, 10:30-11:45 (Room2 / Convention Hall B)

From Clinical Trials to Real-World Evidence inAdvanced Therapy for UC

Chairs	Tadakazu Hisamatsu (Kyorin University)
Chairs	Joo Sung Kim (Seoul National University)
Speakers	Liang Jie (Xijing Hospital)
	David T. Rubin (Chicago University)
	Joyce Mak (Chinese University of Hong Kong)
Co-sponsored by	Janssen Pharmaceutical K.K.